期刊文献+

孕中期化学发光法检测AFP、uE_3、β-HCG在产前筛查的意义 被引量:3

原文传递
导出
摘要 目的探讨利用化学发光法对孕妇孕中期血清甲胎蛋白(AFP)、游离雌三醇(uE3)、β-绒毛膜促性腺激素(β-HCG)进行检测在预防出生缺陷中的价值。尽早发现可能存在的胎儿疾患,以进行早期干预。方法采用化学发光法对孕中期14-21w的孕妇血清中的AFP、uE3、β-HCG进行定量检测,输入孕妇用于筛查的信息后通过专用软件根据三者的浓度计算Down综合征(DS)、18-三体综合征和胎儿神经管缺陷(OSB)的危险性。结果 1338例孕妇筛查出Down综合征(DS)高危110例,高危阳性率为8.22%,18-三体综合征高危7例,高危率为0.52%,神经管缺陷高危(OSB)47例,高危率为3.51%,经随访59例做产前确诊检查,Down综合征阳性1例、经B超检查确诊神经管缺陷(OSB)7例。结论孕中期化学发光法检测用于筛查Down综合征、18-三体综合征、神经管缺陷,预防出生缺陷有重要意义。
作者 陈永秀
出处 《中国优生与遗传杂志》 2013年第7期70-71,共2页 Chinese Journal of Birth Health & Heredity
  • 相关文献

参考文献8

二级参考文献27

  • 1夏燕萍,朱铭伟,李笑天,周和平,王静,吕菊香,Nanbert ZHONG.妊娠中期母血清唐氏综合征三联筛查4680例与不良妊娠结果分析(英文)[J].北京大学学报(医学版),2006,38(1):49-52. 被引量:6
  • 2Wald NJ, Watt HC, Hackshaw AK, et al. First and second trimester antenatal Screening for Down, s syndrome : the results of the Serum, Urine and Ultrasound Screening Study (SURUSS) [J]. Health TecholAssess, 2003, 7 (11): 1-77.
  • 3Boaz W, Charles HR. An update on antenatal screening for Down's syndrome and specific implications for assisted reproduction pregnancies [J]. Hum Reprod Update, 2006, 12 (5) : 513-518.
  • 4Wenstrom KD. Evaluation of Down's syndrome screening strategies [J]. Semin Perinat, 2005, 29: 219-224.
  • 5Palacio M, Jannianx E, Kingdom J, et al. Perinatal outcome in pregnancies with a positive serum screening for Down, s syndrome due to elevated levels of free beta-human chorionic gonadotropin [ J]. Ultrasound Obstet Gynecol, 1999, 13 (1) : 58-62.
  • 6Pavlovic M, Radlovic N, Lekovie Z, et al. Coeliac disease as the cause of resistant sideropenic anaemia in children with Down's syndrome; ease report[J]. Srp Arh eelok Lek,2010,138(1-2):91-94.
  • 7Gidiri M, Holding S, Lindow SW. Reduction in Down' s syndrome screeing acceptance is predominantly observed in Women aged 25-a5 years[J]. Womens Health (Lond Engl), 2010,6 (4): 525-529.
  • 8Abdul-Hamid S, Fox R, Martin I. Maternal serum screening for trisomy 21 in women with a false positive result in last pregnancy. J Obstet Gynaecol, 2004, 24:374 - 376.
  • 9Rahim RR, Cuckle HS, Sehmi IK, et al. Compromise ultrasound dating policy in maternal serum screening for Down syndrome.Prenat Diagn, 2002, 2:1181 - 1184.
  • 10Jou HJ, Wu SC, Lu YM, et al. Weight-correction formula for materhal serum screening for Down syndrome in Taiwan. J Formos Med Assoc, 2000, 99:931 - 935.

共引文献73

同被引文献32

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部